ESC Premium Access

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Congress Presentation

About the speaker

Doctor Erik Bjoerklund

Sahlgrenska Academy, Gothenburg (Sweden)
2 presentations
0 follower

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Speaker: Doctor E. Sorbets (Paris, FR)


Discussant review - CLARIFY

Speaker: Professor D. Hasdai (Petah Tikva, IL)


Questions from the audience and discussion


Discussant review - SWEDEHEART

Speaker: Professor V. Falk (Berlin, DE)


Questions from the audience and discussion


Access the full session

Hot Line Session 5

Speakers: Doctor E. Bjoerklund, Doctor E. Sorbets, Professor D. Hasdai, Professor V. Falk

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb